Cargando…

The 4P: Preventing Preneoplasia through Patients Partnership

SIMPLE SUMMARY: This commentary article is a cross-examination between the research and the associative environments around the cancers of the oral cavity. The authors address the question of a better prevention of oral potentially malignant disorders. They aim to outline the actions that could be d...

Descripción completa

Detalles Bibliográficos
Autores principales: Virgone, Angélique, Badreh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430674/
https://www.ncbi.nlm.nih.gov/pubmed/34503221
http://dx.doi.org/10.3390/cancers13174408
_version_ 1783750758713262080
author Virgone, Angélique
Badreh, Sara
author_facet Virgone, Angélique
Badreh, Sara
author_sort Virgone, Angélique
collection PubMed
description SIMPLE SUMMARY: This commentary article is a cross-examination between the research and the associative environments around the cancers of the oral cavity. The authors address the question of a better prevention of oral potentially malignant disorders. They aim to outline the actions that could be deployed by patient advocacy groups to successfully complete oral potentially malignant disorders prevention challenge. They explain that there is a clear added value of researchers and patient representatives working together to best approach early diagnosis and improve education of disease signs and symptoms by awareness campaigns in addition to the existing, for effective prevention since the beginning. ABSTRACT: The early diagnosis and management of oral potentially malignant disorders (OPMD) represent a unique opportunity to develop strategies that will prevent malignant transformation. Despite a high prevalence, awareness remains low, patient outcomes poor, and quality of life highly affected. How can patient advocacy groups (PAGs) bring more awareness to preneoplasia preceding oral cancers and help patients after the identification of a suspicious oral leukoplakia presented as white patches in the mouth? PAGs are today involved with awareness campaigns, lobbying, and education of both health care systems as well as the survivor and the newly diagnosed. PAGs are a link between the clinician and the patient, making sure that the medical terminology used is explained in layman language and that psychological support is available during and after treatment. This review outlines the actions that could be deployed by PAGs to successfully complete OPMD prevention challenge. The added value of researchers and patient representatives working together is the increased awareness of the problem. To know at which angle to best approach it for encouraging early diagnosis, improved education of disease signs and symptoms will condition effective prevention from the beginning.
format Online
Article
Text
id pubmed-8430674
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84306742021-09-11 The 4P: Preventing Preneoplasia through Patients Partnership Virgone, Angélique Badreh, Sara Cancers (Basel) Commentary SIMPLE SUMMARY: This commentary article is a cross-examination between the research and the associative environments around the cancers of the oral cavity. The authors address the question of a better prevention of oral potentially malignant disorders. They aim to outline the actions that could be deployed by patient advocacy groups to successfully complete oral potentially malignant disorders prevention challenge. They explain that there is a clear added value of researchers and patient representatives working together to best approach early diagnosis and improve education of disease signs and symptoms by awareness campaigns in addition to the existing, for effective prevention since the beginning. ABSTRACT: The early diagnosis and management of oral potentially malignant disorders (OPMD) represent a unique opportunity to develop strategies that will prevent malignant transformation. Despite a high prevalence, awareness remains low, patient outcomes poor, and quality of life highly affected. How can patient advocacy groups (PAGs) bring more awareness to preneoplasia preceding oral cancers and help patients after the identification of a suspicious oral leukoplakia presented as white patches in the mouth? PAGs are today involved with awareness campaigns, lobbying, and education of both health care systems as well as the survivor and the newly diagnosed. PAGs are a link between the clinician and the patient, making sure that the medical terminology used is explained in layman language and that psychological support is available during and after treatment. This review outlines the actions that could be deployed by PAGs to successfully complete OPMD prevention challenge. The added value of researchers and patient representatives working together is the increased awareness of the problem. To know at which angle to best approach it for encouraging early diagnosis, improved education of disease signs and symptoms will condition effective prevention from the beginning. MDPI 2021-08-31 /pmc/articles/PMC8430674/ /pubmed/34503221 http://dx.doi.org/10.3390/cancers13174408 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Virgone, Angélique
Badreh, Sara
The 4P: Preventing Preneoplasia through Patients Partnership
title The 4P: Preventing Preneoplasia through Patients Partnership
title_full The 4P: Preventing Preneoplasia through Patients Partnership
title_fullStr The 4P: Preventing Preneoplasia through Patients Partnership
title_full_unstemmed The 4P: Preventing Preneoplasia through Patients Partnership
title_short The 4P: Preventing Preneoplasia through Patients Partnership
title_sort 4p: preventing preneoplasia through patients partnership
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430674/
https://www.ncbi.nlm.nih.gov/pubmed/34503221
http://dx.doi.org/10.3390/cancers13174408
work_keys_str_mv AT virgoneangelique the4ppreventingpreneoplasiathroughpatientspartnership
AT badrehsara the4ppreventingpreneoplasiathroughpatientspartnership
AT virgoneangelique 4ppreventingpreneoplasiathroughpatientspartnership
AT badrehsara 4ppreventingpreneoplasiathroughpatientspartnership